Recombinant factor IX protein coagulau00c7u00e7o sanguu00cdnea human, composiu00c7u00e7o, use of a recombinant protein of factor IX, the use of a composiu00c7u00e7o, method of obtenu00c7u00e7o of recombinant factor IX protein and use of the same human sanguu00cdnea coagulau00c7u00e7o

摘要

Recombinant factor IX protein coagulau00c7u00e7o sanguu00cdnea human, composiu00c7u00e7o, use of a recombinant protein of factor IX, the use of a composiu00c7u00e7o, method of obtenu00c7u00e7o of recombinant factor IX protein coagulau00c7u00e7o sanguu00cdnea human and use of the same. The present invention relates to a recombinant protein mutated in the human blood coagulation factor IX and a composition that contains.The present invention is also the use of the protein or the composition of the invention for the manufacture of a medicament to treat haemophilia B. in addition, the present invention relates to the method of production of a recombinant protein mutated in the blood coagulation factor IX hum Ana.Still another object of the present invention is mutated recombinant protein obtained by the method described here, and its use to prepare a medicine for the treatment of haemophilia B.